Z

Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079

Watchlist Manager
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
Watchlist
Price: 21.99 CNY 9.57% Market Closed
Market Cap: 4.2B CNY

Profitability Summary

Zhejiang Shengda Bio-Pharm Co Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Zhejiang Shengda Bio-Pharm Co Ltd

Margins Comparison
Zhejiang Shengda Bio-Pharm Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
4.2B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
519.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
274.5B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.7B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.8B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
277.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
146.2B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Zhejiang Shengda Bio-Pharm Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
4.2B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
519.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
274.5B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.7B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.8B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
277.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
146.2B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Zhejiang Shengda Bio-Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate